Downregulation of ST6GAL1 Promotes Liver Inflammation and Predicts Adverse Prognosis in Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most malignant tumors worldwide. The ST6 β-galactoside α-2, 6-sialyltransferase 1 (ST6GAL1) has been found aberrantly expressed in a variety of cancers including HCC, but its function and mechanism in regulating liver inflammation remain to be...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ruijia, Cao, Xu, Liang, Yijun, Li, Xiaobin, Jin, Qian, Li, Ying, Du, Hongbo, Zao, Xiaobin, Ye, Yong’an
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553312/
https://www.ncbi.nlm.nih.gov/pubmed/36238765
http://dx.doi.org/10.2147/JIR.S385491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553312/
https://www.ncbi.nlm.nih.gov/pubmed/36238765
http://dx.doi.org/10.2147/JIR.S385491

Ejemplares similares